...
首页> 外文期刊>Journal of Autoimmunity >Converting antigen-specific diabetogenic CD4 and CD8 T cells to TGF-beta producing non-pathogenic regulatory cells following FoxP3 transduction.
【24h】

Converting antigen-specific diabetogenic CD4 and CD8 T cells to TGF-beta producing non-pathogenic regulatory cells following FoxP3 transduction.

机译:FoxP3转导后,将抗原特异性的致糖尿病性CD4和CD8 T细胞转化为产生TGF-β的非致病性调节细胞。

获取原文
获取原文并翻译 | 示例
           

摘要

Immuno-regulatory defects, including a reduction in the number and function of regulatory T cells, play an important role in the development of autoimmune diabetes in both humans and non-obese diabetic (NOD) mice. In this study we tested the effect of introduction of FoxP3 into antigen non-specific polyclonal and antigen-specific monoclonal T cells on diabetes development in NOD mice. Transduction of FoxP3 into antigen-specific monoclonal (insulin or BDC2.5 mimotope specific) or antigen non-specific polyclonal T cells using retroviral transduction delayed or prevented diabetes development. However, transduced antigen-specific monoclonal T cells were considerably more effective than polyclonal T cells. Regulatory activity was not limited to CD4 T cells as potent diabetogenic CD8 T cells specific for insulin, were also reduced in pathogenicity by FoxP3 induction. The disease suppressive effect, in both CD4 and CD8 cells, was more evident in spontaneously diabetes-prone NOD hosts (non-lymphopenic) than inlymphopenic NOD.scid hosts. We suggest that this strategy of transducing antigen-specific CD4 or CD8 T cells may be a useful therapeutic approach in the prevention of autoimmune diabetes.
机译:免疫调节缺陷,包括调节性T细胞数量和功能的减少,在人类和非肥胖糖尿病(NOD)小鼠自身免疫性糖尿病的发展中起着重要作用。在这项研究中,我们测试了将FoxP3导入抗原非特异性多克隆和抗原特异性单克隆T细胞对NOD小鼠糖尿病发展的影响。使用逆转录病毒转导将FoxP3转导至抗原特异性单克隆抗体(胰岛素或BDC2.5模拟表位特异性)或抗原非特异性多克隆T细胞可延迟或预防糖尿病的发展。然而,转导的抗原特异性单克隆T细胞比多克隆T细胞有效得多。调节活性不仅限于CD4 T细胞,因为对胰岛素具有特异性的有效的致糖尿病性CD8 T细胞,还通过FoxP3诱导降低了致病性。在易发糖尿病的NOD宿主(非淋巴细胞减少型)中,对CD4和CD8细胞的疾病抑制作用比对淋巴细胞减少的NOD.scid宿主更明显。我们建议这种转导抗原特异性CD4或CD8 T细胞的策略可能是预防自身免疫性糖尿病的有用治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号